The First Joint Coordinating Committee (JCC) meeting for the project for Elimination of Lymphatic Filariasis

The first JCC meeting for Phase 2 of the project for the Elimination of Lymphatic Filariasis was held in Port Moresby on the 28^th of June. The purpose was to do an overview and discuss progress, the status of LF measures in each target provinces.

JICA and the Government of Japan have been collaborating with World Health Organization (WHO) and respective Governments of the Pacific islands courtiers in The Pacific Programme for the Elimination of Lymphatic Filariasis (PacELF) for decades, achieving significant milestones. The Provision of Special Medical Equipment for Infection Control (Lymphatic Filariasis) Project, 2000-2016, provided 14 Pacific countries with DEC, one of the drugs used in mass medication for LF control, and test kits. In 2018-2023, the Project for Elimination of Lymphatic Filariasis in the Pacific Region (Phase 1) implemented Mass Drug Administration (MDA) and Transmission Assessment Survey (TAS) in each country and strengthened their capacities for six Pacific countries.

In April 2023, The Lymphatic Filariasis Elimination Project Phase 2 commenced as a continuation of Phase 1. The project is working to strengthen the implementation capacity of MDAs and TAS/IDA impact studies (IIS) in a target seven provinces* in PNG.
Representatives from the target provinces and stakeholders (NDOH, WHO, JICA) attended the project’s JCC.

*New Ireland Province, East New Britain Province, West New Britain Province, East Sepik Province. West Sepik Province, Manus Province, Autonomous Region of Bougainville

Please also visit our Facebook for our latest activities and events news.
JICA Facebook Page